Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer

Clinical trial NCT01520103 · COMPLETED

Trial details

NCT number: NCT01520103
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Her2-negative Metastatic Breast Cancer Her2-negative Locally Advanced Breast Cancer

Start date: 2012-01-01
Primary completion: 2016-10-31
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.